Sex differences in adult depression treatment outcome: An umbrella review of systematic reviews and meta-analyses
Year: 2026
Type: review
Abstract: Major depressive disorder is common and burdensome, with a higher prevalence in women and documented sex differences in treatment response across medicine. However, whether sex differences in adult depression treatment outcomes are consistently reported and synthesized remains unclear. This study aims to synthesize evidence on sex differences in adult depression treatment outcomes and to assess the quality of reviews reporting these differences. It is a secondary analysis of a Campbell Collaboration Evidence and Gap Map (EGM). It is not prospectively registered. PRIOR guidance for overviews of reviews was consulted. We screened 9,475 database records and 995 EGM records; 1,397 full-text reports were assessed, and 48 systematic reviews met inclusion criteria (e.g., reported sex-disaggregated treatment outcomes). We extracted intervention, outcome, and analytical data, assessed methodological quality with AMSTAR-2, and synthesized findings narratively. Among included reviews, 13 (27.1%; 95% CI: 16.6–41.0) found significant sex differences, all with small effect sizes. Pharmacological interventions (selective serotonin reuptake inhibitors, venlafaxine) tended to favor women, psychotherapy (cognitive behavioral therapy, mindfulness) tended to favor men, and complementary and alternative treatments showed variable effects. Over half (52%, 25/48; 95% CI: 38.3–65.5) were critically low quality; 81% (39/48; 95% CI: 68.1–89.8) were low or critically low quality. Sex differences in depression treatment response are underreported. Preliminary trends of female benefit for pharmacotherapy and male benefit for psychotherapy rest on weak evidence. Routine sex-disaggregated reporting and high-quality sex-stratified research are needed. Limitations include restriction to English- and Chinese-language publications, potential overlap of primary studies, and no formal GRADE assessment.
Source: Health Psychology Research
Authors: Liping Guo(Conceptualization, Methodology, Writing – original draft, Writing – review & editing), Jiahui Li(Formal analysis, Writing – review & editing), Yicheng Qian(Formal analysis, Writing – review & editing), Howard White(Conceptualization, Methodology, Writing – original draft, Writing – review & editing), Zhipeng Wei(Conceptualization, Methodology, Writing – review & editing)
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: sex differences, major depressive disorder, depression treatment outcomes, antidepressant treatment, selective serotonin reuptake inhibitors, venlafaxine, cognitive behavioral therapy, mindfulness-based interventions, complementary therapy, methodological quality of systematic reviews, women
Open Access status: gold
Estimated APC paid: $1,200
OpenAlex ID: W7235500490
